Yousif Capital Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.36M | Sell |
41,177
-483
| -1% | -$16K | 0.01% | 955 |
|
2025
Q1 | $1.67M | Sell |
41,660
-1,126
| -3% | -$45.3K | 0.02% | 821 |
|
2024
Q4 | $2.01M | Sell |
42,786
-1,487
| -3% | -$69.9K | 0.02% | 751 |
|
2024
Q3 | $2.34M | Sell |
44,273
-4,823
| -10% | -$255K | 0.03% | 685 |
|
2024
Q2 | $2.66M | Buy |
49,096
+3,663
| +8% | +$198K | 0.03% | 594 |
|
2024
Q1 | $3.19M | Sell |
45,433
-3,496
| -7% | -$245K | 0.04% | 552 |
|
2023
Q4 | $4.09M | Sell |
48,929
-1,494
| -3% | -$125K | 0.05% | 403 |
|
2023
Q3 | $1.49M | Sell |
50,423
-2,877
| -5% | -$84.8K | 0.02% | 908 |
|
2023
Q2 | $1.74M | Sell |
53,300
-2,588
| -5% | -$84.4K | 0.02% | 851 |
|
2023
Q1 | $1.97M | Sell |
55,888
-6,950
| -11% | -$245K | 0.03% | 785 |
|
2022
Q4 | $2.88M | Sell |
62,838
-13,145
| -17% | -$602K | 0.04% | 550 |
|
2022
Q3 | $3.68M | Buy |
75,983
+5,718
| +8% | +$277K | 0.05% | 381 |
|
2022
Q2 | $2.76M | Sell |
70,265
-4,985
| -7% | -$196K | 0.04% | 582 |
|
2022
Q1 | $2.77M | Buy |
75,250
+905
| +1% | +$33.3K | 0.03% | 712 |
|
2021
Q4 | $3.39M | Buy |
+74,345
| New | +$3.39M | 0.04% | 600 |
|